EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Assessing the impact of multidisciplinary team gynecological oncology care in Botswana: A potential model for low‐ and middle‐income countries

Emily MacDuffie, Camille McCallister iD, Jessica George iD, Barati Monare, Rebecca Ketlametswe, Gaobakwe Ramontshonyana, Annah Mmari, Maitumelo Pharithi, Lydiah Mntande, Peter Vuylsteke, Lisa Bazzett-Matabele, Caroline Kernell iD und 5 weitere

Cancer · 2025

DOI: 10.1002/cncr.70006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, 2025. Verfasst von Emily MacDuffie und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Genital Neoplasms, Female, Patient Care Team, Medical Oncology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Center for AIDS Research, Sub-Saharan African Collaborative HIV and Cancer Consortia-U54.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In Botswana, a multidisciplinary team (MDT) clinic was established in 2015 to streamline care for all patients with gynecological malignancies including cervical cancer, Botswana’s leading cause of cancer mortality.

Methods

Patients presenting at the MDT clinic in Gaborone, Botswana, were prospectively enrolled. Temporal trends in stage and treatment distributions were assessed using the Cochran‐Armitage χ 2 test. Overall survival was estimated using the Kaplan‐Meier method.

Results

Between 2015 and 2023, 2345 patients were enrolled. Mean age was 52.0 years (SD 13.1 years) and 62.9% ( n = 1474) were living with HIV. Annual volume increased 4‐fold by 2023. Most patients had cervical cancer (74.3%), followed by vulvar (11.9%), endometrial (8.8%), ovarian (3.6%), and vaginal (1.3%) cancers. Stage distribution was: Stage I 19.2%, Stage II 23.9%, Stage III 31.3%, and Stage IV 9.4%. Trends toward increased diagnosis of Stage I disease ( p < .0018) and decreased diagnosis of Stage II disease ( p = .002) were observed in cervical cancer patients over the years of MDT consultation. Two‐year overall survival for patients with cervical cancer treated between 2015 and 2019 was 67.1% and increased to 75.2% between 2020 and 2024 ( p = .002), potentially driven by increased survival of those with Stage II disease (75.7% vs. 84.8%, p = .025). This coincided with an increase in patients with cervical cancer receiving primary surgery ( p < .001) and a decrease in those receiving radiotherapy with concurrent chemotherapy ( p < .001) and radiotherapy alone ( p < .001).

Discussion

Gynecological cancer outcomes after MDT clinic establishment significantly improved over time. Although ongoing efforts to optimize care are still needed, the success of the MDT clinic in Botswana can serve as a model for coordinated multidisciplinary care in other low‐resource settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genital Neoplasms, FemalePatient Care TeamMedical OncologyHumansFemaleBotswanaMiddle AgedAdultDeveloping CountriesAgedNeoplasm StagingProspective StudiesUterine Cervical Neoplasms

Stichwörter der Autor:innen

cervical cancergynecological cancerlow‐middle income countrymultidisciplinary team

Autor:innen und Institutionen

  • Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Princess Marina Hospital, Gaborone, Botswana.
  • University of Botswana School of Medicine, Gaborone, Botswana.
  • UT Southwestern Medical School, Dallas, Texas, USA.

ORCID-Profile: Camille McCallister, Jessica George, Caroline Kernell

Förderung

  • NCI NIH HHS
  • Center for AIDS Research
  • Sub-Saharan African Collaborative HIV and Cancer Consortia-U54
  • Mentored Patient-Oriented Career Research Development Award
  • Department of Radiation Oncology at the University of Pennsylvania

Zitieren

APA

MacDuffie, E., McCallister, C., George, J., Monare, B., Ketlametswe, R., Ramontshonyana, G., Mmari, A., Pharithi, M., Mntande, L., Vuylsteke, P., Bazzett-Matabele, L., Kernell, C., Hughes, K., Kassick, M., Bvochora-Nsingo, M., Rendle, K. A., & Grover, S. (2025). Assessing the impact of multidisciplinary team gynecological oncology care in Botswana: A potential model for low‐ and middle‐income countries. Cancer. https://doi.org/10.1002/cncr.70006

Vancouver

MacDuffie E, McCallister C, George J, Monare B, Ketlametswe R, Ramontshonyana G, et al. Assessing the impact of multidisciplinary team gynecological oncology care in Botswana: A potential model for low‐ and middle‐income countries. Cancer. 2025. doi:10.1002/cncr.70006

BibTeX
@article{MacDuffie2025,
  author = {MacDuffie, Emily and McCallister, Camille and George, Jessica and Monare, Barati and Ketlametswe, Rebecca and Ramontshonyana, Gaobakwe and Mmari, Annah and Pharithi, Maitumelo and Mntande, Lydiah and Vuylsteke, Peter and Bazzett-Matabele, Lisa and Kernell, Caroline and Hughes, Kgosi and Kassick, Megan and Bvochora-Nsingo, Memory and Rendle, Katharine A and Grover, Surbhi},
  title = {Assessing the impact of multidisciplinary team gynecological oncology care in Botswana: A potential model for low‐ and middle‐income countries},
  journal = {Cancer},
  year = {2025},
  doi = {10.1002/cncr.70006}
}
Kostenlos starten →